Current status of Indian Medicinal Plants with Immunomodulatory potential - A Review

2013 ◽  
Vol 1 (2) ◽  
pp. 73
Author(s):  
Kaliappan Ilango ◽  
Ananth kumar Kammalla ◽  
Govind Prasad Dubey ◽  
Aruna Agrawal
2013 ◽  
Vol 2 (1) ◽  
pp. 13-21 ◽  
Author(s):  
Ramandeep Singh ◽  
Ashraf Ali ◽  
G. Jeyabalan ◽  
Alok Semwal

2011 ◽  
Vol 1 (2) ◽  
pp. S291-S298 ◽  
Author(s):  
Raju Patil ◽  
Ravindra Patil ◽  
Bharati Ahirwar ◽  
Dheeraj Ahirwar

Author(s):  
Bhupinder Kapoor ◽  
Gagandeep Kaur ◽  
Mukta Gupta ◽  
Reena Gupta

  Objective: The objective of this review is to collect and document information on the Indian medicinal plants with anti-gout potential.Methods: Bibliographic investigation was carried out by consulting worldwide scientific databases, analyzing Ayurvedic text books and research journals. The search terms were “gout,” “uric acid,” “hyperuricemia,” “xanthine oxidase (XO) inhibitor and uricosuric.” Herbal keywords included “herbal medicine,” “medicinal plant,” “natural products,” “phytomedicine” and “phytotherapy.”Result and Conclusion: Medicinal plants have been used to treat various ailments since ancient times; hence, ethnobotanical investigations play an important role in pharmacological studies. In India, traditional medicines are being practiced for the treatment of gout and other rheumatic disorders from ancient time. This review provides a comprehensive summary of 130 Indian plants which have been mentioned in ancient literature or used traditionally for the treatment of gout. Out of these, 41 plants have been reported to possess XO inhibitory activity. Further, isolated phytoconstituents having promising XO inhibitor activity are also included in this review. Although a variety of medicinal plants with anti-gout potential have been found in the literature, there is limited information on evaluation of anti-gout activity of isolated phytoconstituents. The current review contains a detailed discussion of the potential of medicinal plants for treatment of gout.  


Pharmacologia ◽  
2013 ◽  
Vol 4 (4) ◽  
pp. 276-284 ◽  
Author(s):  
Ramandeep Singh ◽  
Ashraf Ali ◽  
Sarabjeet Singh

2019 ◽  
Vol 20 (12) ◽  
pp. 1227-1243
Author(s):  
Hina Qamar ◽  
Sumbul Rehman ◽  
D.K. Chauhan

Cancer is the second leading cause of morbidity and mortality worldwide. Although chemotherapy and radiotherapy enhance the survival rate of cancerous patients but they have several acute toxic effects. Therefore, there is a need to search for new anticancer agents having better efficacy and lesser side effects. In this regard, herbal treatment is found to be a safe method for treating and preventing cancer. Here, an attempt has been made to screen some less explored medicinal plants like Ammania baccifera, Asclepias curassavica, Azadarichta indica, Butea monosperma, Croton tiglium, Hedera nepalensis, Jatropha curcas, Momordica charantia, Moringa oleifera, Psidium guajava, etc. having potent anticancer activity with minimum cytotoxic value (IC50 >3μM) and lesser or negligible toxicity. They are rich in active phytochemicals with a wide range of drug targets. In this study, these medicinal plants were evaluated for dose-dependent cytotoxicological studies via in vitro MTT assay and in vivo tumor models along with some more plants which are reported to have IC50 value in the range of 0.019-0.528 mg/ml. The findings indicate that these plants inhibit tumor growth by their antiproliferative, pro-apoptotic, anti-metastatic and anti-angiogenic molecular targets. They are widely used because of their easy availability, affordable price and having no or sometimes minimal side effects. This review provides a baseline for the discovery of anticancer drugs from medicinal plants having minimum cytotoxic value with minimal side effects and establishment of their analogues for the welfare of mankind.


Brittonia ◽  
1987 ◽  
Vol 39 (4) ◽  
pp. 508
Author(s):  
Ghillean T. Prance ◽  
James A. Duke

Sign in / Sign up

Export Citation Format

Share Document